Clinical Trial Update: Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a? [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing whether Interferon Beta-1a improves quality of life in patients with relapsing-remitting multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Interferon beta-1a (Interferon beta-1a)

Snippet

Sponsor: Biogen | Conditions: Relapsing Remitting Multiple Sclerosis | Phase 4 | Status: COMPLETED